You are here: Industry Insights > COVID-19

News List

PMEA 2021: A Celebration of Excellence in Patient Engagement PharmaTimes
December 02, 2021
The 21st annual PMEAs returned to host attendees gathering in-person for a live awards show to recognise the achievement in pharmaceutical marketing excellence.
CHMP issue positive opinion on Comirnaty? for five to 11 year olds EuropeanPharmaceuticalReview
December 02, 2021
Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion on the administration of the companies’ COVID-19...
First Wave BioPharma to continue Covid-19 GI infection therapy trial Pharmaceutical-Technology
December 02, 2021
An independent data monitoring committee (DMC) has recommended First Wave BioPharma to continue enrolment for the second part of its ongoing RESERVOIR Phase II trial of FW-COV to treat gastrointestinal (GI) infections related to Covid-19.
UAE approves Sputnik Light vaccine as universal booster dose for Covid-19 Pharmaceutical-Technology
December 02, 2021
The Russian Direct Investment Fund (RDIF) has announced that the UAE Ministry of Health and Prevention (MOHAP) approved the one-shot Sputnik Light vaccine as a universal booster shot for all the vaccines used in the country for Covid-19.
RedHill Biopharma reports rise in Q3 2021 net revenues Pharmaceutical-Technology
December 02, 2021
RedHill Biopharma has reported net revenues of $21.6m in the third quarter (Q3) of this year, representing an increase from $21.5m in the second quarter of the year.
Late cancer diagnoses rise as NHS struggles with COVID-19 PharmaTimes
December 01, 2021
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic...
Experts considering scientific evidence on need for booster dose against COVID expresspharma
December 01, 2021
The National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) are deliberating and considering scientific evidence for the need and justification for booster dose, Rajya Sabha...
Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant prnasia
December 01, 2021
Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant.
Valneva, IDT Biologika partner to produce Covid-19 vaccines Pharmaceutical-Business-Review
December 01, 2021
French company Valneva and IDT Biologika have partnered to manufacture the former’s inactivated vaccine candidate, VLA2001, for Covid-19.
WHO update on Omicron WorldPharmaNews
December 01, 2021
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron...